Draflazine

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDraflazine
Drug Alias NameR-70380R-75231
ClassificationSmall molecules
Mechanisms of ActionEquilibrative Nucleoside Transporter 1 inhibitors
TargetsEquilibrative Nucleoside Transporter 1
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsIceland
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A